REDUCE LAP-HF II Trial

Publication presented by Frédéric NICOLAS

On February 22, 2022

Title: Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial

Reference: The Lancet, February 2022